Literature DB >> 24407293

A large scale Huntingtin protein interaction network implicates Rho GTPase signaling pathways in Huntington disease.

Cendrine Tourette1, Biao Li, Russell Bell, Shannon O'Hare, Linda S Kaltenbach, Sean D Mooney, Robert E Hughes.   

Abstract

Huntington disease (HD) is an inherited neurodegenerative disease caused by a CAG expansion in the HTT gene. Using yeast two-hybrid methods, we identified a large set of proteins that interact with huntingtin (HTT)-interacting proteins. This network, composed of HTT-interacting proteins (HIPs) and proteins interacting with these primary nodes, contains 3235 interactions among 2141 highly interconnected proteins. Analysis of functional annotations of these proteins indicates that primary and secondary HIPs are enriched in pathways implicated in HD, including mammalian target of rapamycin, Rho GTPase signaling, and oxidative stress response. To validate roles for HIPs in mutant HTT toxicity, we show that the Rho GTPase signaling components, BAIAP2, EZR, PIK3R1, PAK2, and RAC1, are modifiers of mutant HTT toxicity. We also demonstrate that Htt co-localizes with BAIAP2 in filopodia and that mutant HTT interferes with filopodial dynamics. These data indicate that HTT is involved directly in membrane dynamics, cell attachment, and motility. Furthermore, they implicate dysregulation in these pathways as pathological mechanisms in HD.

Entities:  

Keywords:  Cell Death; Cell Motility; Computational Biology; Huntington Disease; Neurodegeneration; Neurodegenerative Diseases; Protein-Protein Interactions; Proteomics; Rho GTPases

Mesh:

Substances:

Year:  2014        PMID: 24407293      PMCID: PMC3945331          DOI: 10.1074/jbc.M113.523696

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  92 in total

1.  Cdc42 induces filopodia by promoting the formation of an IRSp53:Mena complex.

Authors:  S Krugmann; I Jordens; K Gevaert; M Driessens; J Vandekerckhove; A Hall
Journal:  Curr Biol       Date:  2001-10-30       Impact factor: 10.834

Review 2.  Integrating 'omic' information: a bridge between genomics and systems biology.

Authors:  Hui Ge; Albertha J M Walhout; Marc Vidal
Journal:  Trends Genet       Date:  2003-10       Impact factor: 11.639

3.  Regulation of IRSp53-dependent filopodial dynamics by antagonism between 14-3-3 binding and SH3-mediated localization.

Authors:  Jeffrey M Robens; Lee Yeow-Fong; Elsa Ng; Christine Hall; Ed Manser
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

4.  The structure of an FF domain from human HYPA/FBP11.

Authors:  Mark Allen; Assaf Friedler; Oliver Schon; Mark Bycroft
Journal:  J Mol Biol       Date:  2002-10-25       Impact factor: 5.469

5.  Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.

Authors:  Haibing Jiang; Michelle A Poirier; Yideng Liang; Zhong Pei; Charlotte E Weiskittel; Wanli W Smith; Donald B DeFranco; Christopher A Ross
Journal:  Neurobiol Dis       Date:  2006-09       Impact factor: 5.996

6.  Degradation of mutant huntingtin via the ubiquitin/proteasome system is modulated by FE65.

Authors:  Wan Ning Vanessa Chow; Hon Wing Luk; Ho Yin Edwin Chan; Kwok-Fai Lau
Journal:  Biochem J       Date:  2012-05-01       Impact factor: 3.857

7.  Ena/VASP Is Required for neuritogenesis in the developing cortex.

Authors:  Adam V Kwiatkowski; Douglas A Rubinson; Erik W Dent; J Edward van Veen; Jonathan D Leslie; Jiangyang Zhang; Leslie M Mebane; Ulrike Philippar; Elaine M Pinheiro; Aurora A Burds; Roderick T Bronson; Susumu Mori; Reinhard Fässler; Frank B Gertler
Journal:  Neuron       Date:  2007-11-08       Impact factor: 17.173

8.  Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.

Authors:  Cheryl L Wellington; Lisa M Ellerby; Claire-Anne Gutekunst; Danny Rogers; Simon Warby; Rona K Graham; Odell Loubser; Jeremy van Raamsdonk; Roshni Singaraja; Yu-Zhou Yang; Juliette Gafni; Dale Bredesen; Steven M Hersch; Blair R Leavitt; Sophie Roy; Donald W Nicholson; Michael R Hayden
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

9.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.

Authors:  Brinda Ravikumar; Coralie Vacher; Zdenek Berger; Janet E Davies; Shouqing Luo; Lourdes G Oroz; Francesco Scaravilli; Douglas F Easton; Rainer Duden; Cahir J O'Kane; David C Rubinsztein
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

Review 10.  Inositol polyphosphate multikinase signaling in the regulation of metabolism.

Authors:  Joo-Young Lee; Young-ran Kim; Jina Park; Seyun Kim
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

View more
  32 in total

1.  Quantitative Proteomic Analysis Reveals Similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human Brains.

Authors:  Tamara Ratovitski; Raghothama Chaerkady; Kai Kammers; Jacqueline C Stewart; Anialak Zavala; Olga Pletnikova; Juan C Troncoso; Dobrila D Rudnicki; Russell L Margolis; Robert N Cole; Christopher A Ross
Journal:  J Proteome Res       Date:  2016-08-03       Impact factor: 4.466

Review 2.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

3.  A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine.

Authors:  Andrew M Stern; Mark E Schurdak; Ivet Bahar; Jeremy M Berg; D Lansing Taylor
Journal:  J Biomol Screen       Date:  2016-03-08

4.  Integration-independent Transgenic Huntington Disease Fragment Mouse Models Reveal Distinct Phenotypes and Life Span in Vivo.

Authors:  Robert O'Brien; Francesco DeGiacomo; Jennifer Holcomb; Akilah Bonner; Karen L Ring; Ningzhe Zhang; Khan Zafar; Andreas Weiss; Brenda Lager; Birgit Schilling; Bradford W Gibson; Sylvia Chen; Seung Kwak; Lisa M Ellerby
Journal:  J Biol Chem       Date:  2015-05-29       Impact factor: 5.157

5.  Decreased FAK activity and focal adhesion dynamics impair proper neurite formation of medium spiny neurons in Huntington's disease.

Authors:  Hae Nim Lee; Seung Jae Hyeon; Heejung Kim; Kyoung Mi Sim; Yunha Kim; Jeongmin Ju; Junghee Lee; Yingxiao Wang; Hoon Ryu; Jihye Seong
Journal:  Acta Neuropathol       Date:  2022-07-20       Impact factor: 15.887

6.  HAP40 is a conserved central regulator of Huntingtin and a potential modulator of Huntington's disease pathogenesis.

Authors:  Shiyu Xu; Gang Li; Xin Ye; Dongsheng Chen; Zhihua Chen; Zhen Xu; Moretti Daniele; Sara Tambone; Alessandra Ceccacci; Licia Tomei; Lili Ye; Yue Yu; Amanda Solbach; Stephen M Farmer; Erin Furr Stimming; George McAllister; Deanna M Marchionini; Sheng Zhang
Journal:  PLoS Genet       Date:  2022-07-19       Impact factor: 6.020

7.  Huntingtin Co-Isolates with Small Extracellular Vesicles from Blood Plasma of TgHD and KI-HD Pig Models of Huntington's Disease and Human Blood Plasma.

Authors:  Hanadi Ananbeh; Jaromir Novak; Stefan Juhas; Jana Juhasova; Jiri Klempir; Kristyna Doleckova; Irena Rysankova; Karolina Turnovcova; Jaroslav Hanus; Hana Hansikova; Petr Vodicka; Helena Kupcova Skalnikova
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

Review 8.  Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

9.  Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases.

Authors:  William Guiler; Addison Koehler; Christi Boykin; Qun Lu
Journal:  Front Cell Neurosci       Date:  2021-05-12       Impact factor: 5.505

Review 10.  Taming the Huntington's Disease Proteome: What Have We Learned?

Authors:  Connor Seeley; Kimberly B Kegel-Gleason
Journal:  J Huntingtons Dis       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.